BioReference Laboratories, Inc. Announces 35% Increase in Net Revenues, 50% Increase in Operating Income, Year Over Year

BioReference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $65,961, the best ever quarter in terms of revenues in corporate history and an increase of 35% over the $49,026 recorded in the third quarter, fiscal year 2006. Net income after taxes in Q3FY07 was $4,189 resulting in fully diluted earnings per share (EPS) of $.30, up 14% from the prior fiscal year third quarter net income after taxes of $3,679 and EPS of $.27. Gross profits on revenues for the current quarter were $33,494 resulting in a margin for gross profit on revenues of 51%, versus the $24,343...

Want to see the full article?

• Purchase this article for only $3.00